Form 4: KORU Medical Systems: Insider Stock Transactions
Insider Transaction Report
Thomas Edward Adams, Chief Financial Officer of KORU Medical Systems, Inc., reported transactions involving common stock, including the acquisition of 8,193 shares upon vesting of restricted stock units and the withholding of 2,900 shares for tax obligations.
Summary
- Thomas Edward Adams, Chief Financial Officer of KORU Medical Systems, Inc. (KRMD), reported transactions on May 14, 2026.
- Adams acquired 8,193 shares of common stock upon the vesting of restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of common stock upon vesting.
- Additionally, 2,900 shares were withheld to satisfy tax obligations related to the vesting of RSUs.
- Following these transactions, Adams beneficially owns 313,440 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions related to compensation rather than significant strategic moves or performance indicators.
Positives
- Vesting of restricted stock units indicates employee/executive compensation and potential alignment with company performance.
- Acquisition of shares by a key executive can be interpreted as a positive signal of confidence in the company's future.
Negatives
- Withholding of 2,900 shares to cover tax obligations represents a reduction in the net shares received by the reporting person.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings, like this one from KORU Medical Systems, are standard disclosures for insider stock transactions. These reports provide transparency into the holdings and activities of company executives and directors, offering insights into their confidence in the company's prospects.
Stakeholder Impact
- Shareholders: Gain insight into insider activity, which can sometimes influence market perception.
- Employees: The vesting of RSUs for executives may reflect the company's compensation strategy and performance metrics.
- Management: The transaction reflects the standard compensation and tax management practices for executives.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Transaction Date for acquisition and withholding of common stock. |
| 05/18/2026 | Date of signature for the filing. |
Keywords
KORU Medical Systems, KRMD, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Chief Financial Officer, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.